Skip to main content

Table 1 Tumor cell lines, host mice, protocol variances

From: Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies

Tumor typea

Tumor name

Histology

Mouse strain

Comments

Breast

MCF7b

Adenocarcinoma

nu/nu NCr

2 samples P0, 4 samples P1

 

MDA-MB-231 T

Adenocarcinoma, from mouse

nu/nu NCr

2 samples P0

Cervical

HeLa-Luc

Adenocarcinoma

nu/nu NCr

2 samples P0

CNS

SF-268c

Anaplastic Astrocytoma

NOD.SCID/NCr

2 samples P0, P4 and P10 are mouse

 

SF-539c

Glioblastoma

NOD.SCID/NCr

2 samples P0, P4 and P10 are mouse

 

U251

Glioblastoma

nu/nu NCr

2 samples P0

Colon

COLO 205

Adenocarcinoma

nu/nu NCr

 
 

HCC-2998

Carcinoma

nu/nu NCr

 
 

HCT-116

Carcinoma

nu/nu NCr

 
 

HCT-15

Adenocarcinoma

nu/nu NCr

 
 

HT-29

Adenocarcinoma, GR III

nu/nu NCr

 
 

KM12

Adenocarcinoma

nu/nu NCr

 
 

SW-620

Adenocarcinoma

nu/nu NCr

 

Gastric

GTL 16

Adenocarcinoma

nu/nu NCr

2 samples P0

Leukemia/

AS283

AIDs related Burkitts Lymphoma

SCID/NCr

2 samples P0

Lymphoma

CA46

B Lymphocyte Burkitts Lymphoma

SCID/NCr

2 samples P0

 

CCRF-CEM

Acute Lymphoblastic Leukemia (T-ALL)

SCID/NCr

 
 

HL-60(TB)

Promyelocytic Leukemia

SCID/NCr

3 samples P5 substituted for P4; 4 P0 samples

 

K-562

Chronic Myelogenous Leukemia

SCID/NCr

5 samples P5 substituted for P4, 4 samples P10

 

MOLT-4

Acute Lymphoblastic Leukemia

SCID/NCr

 
 

SR

Large Cell, Immunoblastic

SCID/NCr

 

Liver

HuH-7

Differentiated Hepatocellular Carcinoma

nu/nu NCr

2 samples P0

Lung

A549

Adenocarcinoma

nu/nu NCr

 
 

A549/Asc-1

Adenocarcinoma

nu/nu NCr

3 samples P4, 2 samples P0

 

EKVX

Adenocarcinoma

SCID/NCr

2 samples P0

 

HOP-62

Adenocarcinoma

nu/nu NCr

4 samples P1

 

HOP-92

Large Cell, undifferentiated

nu/nu NCr

 
 

NCI-H226

Squamous Carcinoma

nu/nu NCr

2 samples P1

 

NCI-H23

Adenocarcinoma, NSCLC

nu/nu NCr

2 samples P0

 

NCI-H460

Large Cell Carcinoma

nu/nu NCr

 
 

NCI-H522

Adenocarcinoma

nu/nu NCr

2 samples P0

Melanoma

A375

Metastatic Malignant Melanoma

nu/nu NCr

2 samples P0

 

COLO 829

Malignant Melanoma

nu/nu NCr

2 samples P0

 

LOX IMVI

Malignant Amelanocytic Melanoma

nu/nu NCr

2 samples P0

 

M14

Adenocarcinoma

nu/nu NCr

2 samples P0

 

MALME-3 M

Malignant Melanoma

nu/nu NCr

2 samples P0, 4 samples P4

 

MDA-MB-435

Adenocarcinoma

nu/nu NCr

2 samples P0, 3 samples P10

 

MDA-Nd

HER2/ERB2 transfectant of MDA-MB-435

nu/nu NCr

2 samples P0

 

UACC-62

Malignant Melanoma

nu/nu NCr

 

Ovarian

CP70

Carcinoma

nu/nu NCr

2 samples P0

 

OVCAR-3

Adenocarcinoma

nu/nu NCr

2 samples P0

 

OVCAR-5

Carcinoma

nu/nu NCr

2 samples P0

Pancreatic

AsPC-1

Adenocarcinoma

nu/nu NCr

2 samples P0

Prostate

PC-3

Adenocarcinoma

Male nu/nu NCr

2 samples P0

 

PC-3/Me

Metastatic PC-3 subline

Male nu/nu NCr

 

Renal

786-0

Adenocarcinoma

nu/nu NCr

 
 

CAKI-1

Renal Cell Carcinoma

nu/nu NCr

2 samples P0

 

RXF 393

Poorly Differentiated Hypernephroma

nu/nu NCr

 
 

SN12C

Carcinoma

nu/nu NCr

2 samples P0

  1. aTumor cells derived from the 4th in vitro passage were innoculated subcutaneously into mice. Tumors were passaged 10 consecutive times in mice. At passages 1, 4, and 10 (P1, P4, P10, respectively), 5 tumors were harvested, cut into small pieces and flash frozen in liquid nitrogen. Samples were then processed as described in Methods. For comparative purposes, 3 samples of the in vitro cultivated cells at passage 4 (P0) were also prepared for microarray analysis.
  2. b3 mg/kg Q7D SC Estradiol.
  3. cMatrigel 18.1 mg/mL P1 only.
  4. dHER2/ERBB2 transfectant of MDA-MB-435.
  5. ePC3 subline isolated from liver metastasis in mice.